Explore the latest advancements in HER2-positive breast cancer treatments, highlighting the promising results of DESTINY-Breast trials for improved patient outcomes.
Jules Cohen, MD
Advertisement
Articles by Jules Cohen, MD
Discover how advancements in HER2-positive breast cancer treatment enhance patient outcomes through personalized therapies and innovative strategies for both early and metastatic stages.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Oral Semaglutide as First GLP-1 Pill for Weight Loss
2
Multi-Stakeholder Collaboration Is Essential to Achieve Equity in IPF Care
3
Duration of Response With Sonrotoclax Vs Current Therapies for MCL
4
Evolving Horizons in HER2-Positive Breast Cancer Care
5
